Innovative Biomarkers for Obesity and Type 1 Diabetes Based on Bifidobacterium and Metabolomic ProfilingArticle Published on 2024-05-032024-09-05 Journal: Microorganisms [Category] update2024, [키워드] Bifidobacterium Branched amino acids capillary electrophoresis children gut microbiome obesity short-chain fatty acids Type 1 diabetes [DOI] 10.3390/microorganisms12050931 PMC 바로가기 [Article Type] Article
[Meta-analysis of the clinical efficacy of live bifidobacterium bacteria preparation combined with entecavir in the treatment of hepatitis B virus-related cirrhosis]Meta-Analysis Published on 2023-03-202023-06-13 Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese [Category] B형 간염, [키워드] Bifidobacterium entecavir hepatitis B Liver cirrhosis Meta analysis [DOI] 10.3760/cma.j.cn501113-20230309-00097 [Article Type] Meta-Analysis
Detection of Intestinal Dysbiosis in Post-COVID-19 Patients One to Eight Months after Acute Disease Resolution급성 질환 해결 후 1~8개월 후 코로나19 환자의 장내 세균총 이상 감지Article Published on 2022-08-172022-09-11 Journal: International Journal of Environmental Research an [Category] 치료제, [키워드] acute COVID-19 acute disease acute phase adaptive immune responses addition alopecia anti-SARS-CoV-2 antibody Antibiotic therapy Antibiotics Anxiety bidirectional Bifidobacterium C-reactive protein Clinical data clinical manifestations controls COVID-19 severity Cytokine storm Depression Desulfovibrio detection disease DNA Dysbiosis Dyspnea evaluate fatigue Hypothesis immune response immune responses Immune status Interaction intestinal intestinal microbiota memory memory loss microbes microbiota modulating modulation Month myalgia pandemic Patient post-COVID-19 Post-COVID-19 patients Prevotella quantified reported symptoms Resolution Sequelae sequenced severity significant difference significant differences Stool stool samples target the patient Therapeutic approach These data use of antibiotics viral infections with COVID-19 [DOI] 10.3390/ijerph191610189 PMC 바로가기 [Article Type] Article
Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events장내 미생물 조성은 SARS-CoV-2 백신 면역원성 및 부작용과 관련이 있습니다.Observational Study Published on 2022-06-012022-09-12 Journal: Gut [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] adverse event Anti-inflammatory antibody association Bacteria Bacterial baseline Bifidobacterium BNT162b2 BNT162b2 vaccine carbohydrate collected complement conducted CoronaVac COVID-19 COVID-19 vaccinee COVID-19 vaccines Effectiveness enteric bacterial microflora flagella Gut gut microbiota gut microbiota composition high neutralising antibody Host immune response IgG ELISA immune response Inactivated vaccine individual Intervention Linear Discriminant Analysis marker metabolism metagenomic sequencing Microbiome microbiota modulating mRNA vaccine pathway performed positive correlation Prevotella recipient reduced SARS-CoV-2 SARS-CoV-2 vaccine second dose significantly lower Sinovac spike receptor-binding domain Stool subject the vaccine vaccination Vaccine vaccinee vaccinees Virus neutralisation were measured [DOI] 10.1136/gutjnl-2021-326563 PMC 바로가기 [Article Type] Observational Study
Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome급성 COVID-19 증후군 환자의 전향적 코호트에서 장내 미생물 역학Multicenter Study Published on 2022-03-012022-09-11 Journal: Gut [Category] SARS, 유전자 메커니즘, [키워드] Actinomyce Actinomyces Admission alteration analysed Bacteria Bacteroide Bifidobacterium Butyrate clearance Clostridium comparable Complication complications of COVID-19 conducted controls correlated COVID-19 COVID-19 severity defined Evidence evidence of facilitate Faecalibacterium fatigue Gut gut microbiome gut microbiome composition gut microbiota composition Hair loss intestinal INTESTINAL MICROBIOLOGY inverse correlation memory metagenomic sequencing Microbiome microbiota modulation Neuropsychiatric Non-COVID-19 nosocomial Occurrence Pathogens Patient persistent poor memory prospective cohort Prospective Study provided respiratory symptom SARS-CoV-2 virus shotgun Spectrum Symptom syndrome the SARS-CoV-2 virus viral clearance [DOI] 10.1136/gutjnl-2021-325989 PMC 바로가기 [Article Type] Multicenter Study
A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19Cellular and Infection Microbiology Published on 2021-11-172022-10-31 Journal: Frontiers in Cellular and Infection Microbiology [Category] COVID-19, MERS, SARS, [키워드] 16S rRNA gene Actinobacteria analyzed Anti-inflammatory Associate Bacterial Bacteroide Bacteroidete Bifidobacterium Blood Care CD8 characterized connectivity contribute COVID-19 COVID-19 illness COVID-19 severity decrease Dysbiosis dysregulated Enterobacteriaceae exhibited Faecalibacterium Gut gut microbiome composition gut microbiota Health hospital Hyperinflammatory Immune cell immune response immune responses infected with SARS-CoV-2 intestinal microbiota marker Microbiome mild COVID-19 illness network Patient patients pro-inflammatory Prospective Study Proteobacteria quantified reduction in SARS-CoV-2 SARS-CoV-2 infected patient SARS-CoV-2 positive patient Sequencing severe COVID-19 illness severity Streptococcus T cell was increased [DOI] 10.3389/fcimb.2021.747816 PMC 바로가기 [Article Type] Cellular and Infection Microbiology
Double-Barrel Shotgun: Probiotic Lactic Acid Bacteria with Antiviral Properties Modified to Serve as VaccinesReview Published on 2021-07-232022-10-29 Journal: Microorganisms [Category] COVID-19, [키워드] acid antibodies Antiviral antiviral properties Bacteria Bifidobacterium Cell COVID-19 elicit Host host’s immune response hypothesised immune immune response in viral Infection intestinal lactic lactic acid Lactic acid bacteria metabolite microbiota pandemic peptides Prevent Probiotic property question SARS-CoV SARS-CoV spike protein shown stimulate strain Vaccine Vaccines Viral antigen viral infections viral replication [DOI] 10.3390/microorganisms9081565 PMC 바로가기 [Article Type] Review
Genome Features and In Vitro Activity against Influenza A and SARS-CoV-2 Viruses of Six Probiotic StrainsResearch Article Published on 2021-06-182022-10-27 Journal: BioMed Research International [Category] Coronavirus, COVID-19, Fulltext, MERS, SARS, 신종인플루엔자, [키워드] activity Antibiotic resistance Antibiotics antiviral activity Bacterial Bifidobacterium Bifidobacterium longum biochemical caused cells Complete demonstrated determinant determine disease explained Genome H1N1 Human Illumina Inc infect influenza A influenza A virus Influenza virus intestine lactobacillus MDCK cells MiSeq molecular nonpathogenic plasmids platform Probiotic probiotic bacteria resistance respiratory virus Result Safe SARS-CoV-2 SARS-CoV-2 virus strain SARS-CoV-2 viruses strain Strains the SARS-CoV-2 virus was performed were used Whole genome sequencing [DOI] 10.1155/2021/6662027 PMC 바로가기 [Article Type] Research Article
Genome Features and In Vitro Activity against Influenza A and SARS-CoV-2 Viruses of Six Probiotic StrainsResearch Article Published on 2021-06-182022-10-27 Journal: BioMed Research International [Category] COVID-19, [키워드] activity Antibiotic resistance Antibiotics antiviral activity Bacterial Bifidobacterium Bifidobacterium longum biochemical caused cells Complete demonstrated determinant determine disease explained Genome H1N1 Human Illumina Inc infect influenza A influenza A virus Influenza virus intestine lactobacillus MDCK cells MiSeq molecular nonpathogenic plasmids platform Probiotic probiotic bacteria resistance respiratory virus Result Safe SARS-CoV-2 SARS-CoV-2 virus strain SARS-CoV-2 viruses strain Strains the SARS-CoV-2 virus was performed were used Whole genome sequencing [DOI] 10.1155/2021/6662027 PMC 바로가기 [Article Type] Research Article
Investigation of Nasal/Oropharyngeal Microbial Community of COVID-19 Patients by 16S rDNA SequencingArticle Published on 2021-02-232022-10-29 Journal: International Journal of Environmental Research an [Category] COVID-19, MERS, [키워드] 16S rRNA gene admitted to ICU affected Bifidobacterium characterized Clostridium Control controls country COVID-19 decrease eight facilitate human coronavirus ICU ICU Patients information intensive care unit investigation marker microbiota Modification Nasal/Oropharyngeal negative control NL63 OC43 Other other coronaviruses outcome pandemic Patient patients performed profile Prognosis rDNA resulting Salmonella SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 patient SARS-CoV-2 patients SARS-CoV2 Sequencing severity significant decrease significantly Stratification the disease [DOI] 10.3390/ijerph18042174 PMC 바로가기 [Article Type] Article